|
VANGL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.719990E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.502180E-02 |
| Normal-vs-Stage2 |
2.490400E-01 |
| Normal-vs-Stage3 |
8.564800E-01 |
| Normal-vs-Stage4 |
4.930400E-01 |
| Stage1-vs-Stage2 |
8.395200E-01 |
| Stage1-vs-Stage3 |
9.299900E-02 |
| Stage1-vs-Stage4 |
8.995400E-01 |
| Stage2-vs-Stage3 |
3.087800E-01 |
| Stage2-vs-Stage4 |
9.860400E-01 |
| Stage3-vs-Stage4 |
4.426200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.942800E-03 |
| Normal-vs-AfricanAmerican |
1.200210E-01 |
| Normal-vs-Asian |
4.756600E-01 |
| Caucasian-vs-AfricanAmerican |
5.809800E-01 |
| Caucasian-vs-Asian |
7.335800E-01 |
| AfricanAmerican-vs-Asian |
8.888000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.601400E-04 |
| Normal-vs-Female |
4.637000E-01 |
| Male-vs-Female |
1.059190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.219240E-01 |
| Normal-vs-Extreme_Weight |
3.89600000000323E-05 |
| Normal-vs-Obese |
2.685200E-01 |
| Normal-vs-Extreme_Obese |
4.568400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.210000E-01 |
| Normal_Weight-vs-Obese |
5.260200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.095800E-01 |
| Extreme_Weight-vs-Obese |
1.524250E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.798000E-01 |
| Obese-vs-Extreme_Obese |
8.991800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.338200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.061400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.167800E-04 |
| Normal-vs-Age(81-100Yrs) |
6.404200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.715700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.360200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.163300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.971600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.738000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.183200E-04 |
| Normal-VS-Type2 PRCC |
1.294570E-01 |
| Normal-VS-KIRP CIMP |
1.234220E-01 |
| Normal-VS-Unclassified PRCC |
2.562800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.462600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.980200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.980980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.013820E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.064800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.534300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.933900E-02 |
| Normal-vs-N1 |
7.858400E-01 |
| Normal-vs-N2 |
9.821800E-01 |
| N0-vs-N1 |
1.066010E-01 |
| N0-vs-N2 |
4.803400E-01 |
| N1-vs-N2 |
9.373600E-01 |
|
|
